Ruonan Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ruonan Zhang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Xuehua Li
Department of Radiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
3 shared publications Lili Huang
Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Rd, Guangzhou 510080, People’s Republic of China
2 shared publicationsLuyao Wu
Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Rd, Guangzhou 510080, People’s Republic of China
2 shared publicationsQingzhu Zheng
Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Rd, Guangzhou 510080, People’s Republic of China
2 shared publicationsRen Mao
Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
2 shared publications- Yangdi Wang
Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Rd, Guangzhou 510080, People’s Republic of China
2 shared publications
Latest Publications
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (2) , e252429
MR Elastography Characterization of Biomechanical Properties to Enhance Enterographic Fibrosis Diagnosis
In participants with Crohn disease, MR elastography quantified tissue biomechanics, and incorporation of MR elastography improved the diagnostic performance of MR enterography for intestinal fibrosis stratification in Crohn disease.
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (2) , e252429
MR Elastography Characterization of Biomechanical Properties to Enhance Enterographic Fibrosis Diagnosis
In participants with Crohn disease, MR elastography quantified tissue biomechanics, and incorporation of MR elastography improved the diagnostic performance of MR enterography for intestinal fibrosis stratification in Crohn disease.
- Open Access
- 13 September 2024
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 16 (10) , 2427-2449
Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn’s disease
Intestinal fibrosis is the primary cause of disability in patients with Crohn’s disease (CD), yet effective therapeutic strategies are currently lacking. Here, we report a multiomics analysis of gut microbiota and fecal/blood metabolites of 278 CD patients and 28 healthy controls, identifying characteristic alterations in gut microbiota (e.g., Lachnospiraceae , Ruminococcaceae , Muribaculaceae , Saccharimonadales ) and metabolites (e.g., L -aspartic acid, glutamine, ethylmethylacetic acid) in moderate-severe intestinal fibrosis. By integrating multiomics data with magnetic resonance enterography features, putative links between microbial metabolites and intestinal fibrosis-associated morphological alterations were established. These potential associations were mediated by specific combinations of amino acids (e.g., L -aspartic acid), primary bile acids, and glutamine. Finally, we provided causal evidence that L -aspartic acid aggravated intestinal fibrosis both in vitro and in vivo. Overall, we offer a biologically plausible explanation for the hypothesis that gut microbiota and its metabolites promote intestinal fibrosis in CD while also identifying potential targets for therapeutic trials.
- 13 September 2024
- Published by Springer Nature in EMBO Molecular Medicine
- Vol. 16 (10) , 2427-2449
Open AccessMultiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn’s disease
Intestinal fibrosis is the primary cause of disability in patients with Crohn’s disease (CD), yet effective therapeutic strategies are currently lacking. Here, we report a multiomics analysis of gut microbiota and fecal/blood metabolites of 278 CD patients and 28 healthy controls, identifying characteristic alterations in gut microbiota (e.g., Lachnospiraceae , Ruminococcaceae , Muribaculaceae , Saccharimonadales ) and metabolites (e.g., L -aspartic acid, glutamine, ethylmethylacetic acid) in moderate-severe intestinal fibrosis. By integrating multiomics data with magnetic resonance enterography features, putative links between microbial metabolites and intestinal fibrosis-associated morphological alterations were established. These potential associations were mediated by specific combinations of amino acids (e.g., L -aspartic acid), primary bile acids, and glutamine. Finally, we provided causal evidence that L -aspartic acid aggravated intestinal fibrosis both in vitro and in vivo. Overall, we offer a biologically plausible explanation for the hypothesis that gut microbiota and its metabolites promote intestinal fibrosis in CD while also identifying potential targets for therapeutic trials.
- Open Access
- 3 December 2022
- Published by Wiley in United European Gastroenterology Journal
- Vol. 10 (10) , 1179-1193
Inflammatory bowel disease cross‐sectional imaging: What's new?
Cross‐sectional imaging—ultrasonography, computed tomography enterography, and magnetic resonance enterography—is a routine and indispensable tool for patients with Crohn's disease (CD) that helps to detect or monitor disease characteristics before, during, and after CD treatment. New emerging radiological technologies may have further clinical applications in the management of CD. In this review article, we focus on the latest developments in cross‐sectional imaging in CD research, including its role in intra‐ and extra‐luminal lesion detection, intestinal inflammation and fibrosis grading, therapeutic response assessment and outcome prediction, postoperative recurrence detection and prediction, and the gut‐brain axis.
- 3 December 2022
- Published by Wiley in United European Gastroenterology Journal
- Vol. 10 (10) , 1179-1193
Open AccessInflammatory bowel disease cross‐sectional imaging: What's new?
Cross‐sectional imaging—ultrasonography, computed tomography enterography, and magnetic resonance enterography—is a routine and indispensable tool for patients with Crohn's disease (CD) that helps to detect or monitor disease characteristics before, during, and after CD treatment. New emerging radiological technologies may have further clinical applications in the management of CD. In this review article, we focus on the latest developments in cross‐sectional imaging in CD research, including its role in intra‐ and extra‐luminal lesion detection, intestinal inflammation and fibrosis grading, therapeutic response assessment and outcome prediction, postoperative recurrence detection and prediction, and the gut‐brain axis.
- 29 May 2014
- Published by Wiley in Medical Physics
- Vol. 41 (6Part21) , 376
SU-E-T-643: A Comparison of the DTA and Gamma Index Analysis for IMRT/VMAT Plans in Rectal Carcinoma
- 29 May 2014
- Published by Wiley in Medical Physics
- Vol. 41 (6Part21) , 376
SU-E-T-643: A Comparison of the DTA and Gamma Index Analysis for IMRT/VMAT Plans in Rectal Carcinoma